Case Report: Clinical Case Report of Community-Acquired Pneumonia with Parapneumonic Effusion and Multiple Comorbidities in a Middle-Aged Male
- Authors
-
-
Syazili Mustofa
Fakultas Kedokteran Universitas Lampung
-
Latansa Amani Raya
Fakultas Kedokteran, Universitas Lampung
-
Giska Tri Putri
Fakultas Kedokteran Universitas Lampung
-
Hendri Busman
Fakultas Matematika dan Ilmu Pengetahuan Alam Universitas Lampung
-
- Keywords:
- Array, Array, Array, Array, Array
- Abstract
-
Community-acquired pneumonia (CAP) complicated by parapneumonic pleural effusion presents significant management challenges, especially in patients with multiple comorbidities such as congestive heart failure (CHF), type 2 diabetes mellitus (DM), and hepatobiliary insufficiency. A 42-year-old male security officer presented with progressive dyspnea, productive cough with hemoptysis, and right pleural effusion. Examination revealed asymmetrical thorax, signs of right-sided pleural effusion, hepatomegaly, ascites, and pitting edema. Laboratory findings showed leukocytosis, hypoalbuminemia, hyponatremia, and impaired liver and kidney function. Imaging confirmed community-acquired pneumonia (CAP) with right parapneumonic effusion. Echocardiography showed congestive heart failure (CHF) with reduced ejection fraction (19%) and intracardiac thrombi. Treatment included oxygen therapy, antibiotics, diuretics, insulin, and supportive care. The patient improved gradually, emphasizing the need for a multidisciplinary approach in managing CAP with pleural effusion and underlying comorbidities.
- References
-
1. Tanaka K, et al. Karakteristik klinis infeksi pleura primer yang didapat di masyarakat. Journal of Respiratory Infections. 2023;58(2):45-52.
2. Zhang Y, et al. Dampak komorbiditas terhadap prognosis pneumonia akut berat yang didapat di masyarakat. Journal of Infectious Diseases. 2023;230(4):567-73.
3. Chen H, et al. Peran computed tomography dada pada pasien rawat inap dengan pneumonia komunitas. Journal of Thoracic Imaging. 2024;38(5):345-52.
4. Wang L, et al. Pembaruan tentang pengelolaan pneumonia yang didapat di masyarakat di ICU. Critical Care Medicine. 2022;50(11):1234-42.
5. Lee J, et al. Terapi antibiotik empiris untuk pneumonia yang didapat di masyarakat dengan tingkat keparahan sedang hingga berat. Canadian Journal of Infectious Diseases & Medical Microbiology. 2023;45(2):78-84.
6. Zhang W, et al. Pembaruan dalam pengelolaan pneumonia yang didapat di masyarakat di ICU. Journal of Clinical Microbiology and Infectious Diseases. 2024;34(6):456-63.
7. Alderwick H, Dunn P, McCullough A. Peran asam tranexamic dalam pengelolaan hemoptisis dan kondisi pernapasan: Tinjauan komprehensif. Journal of Respiratory Medicine. 2022;55(3):223-30.
8. Cheng Y, Zhang Z, Guo J. Hiperglikemia sebagai faktor risiko hasil buruk pada pneumonia: Tinjauan sistematis dan meta-analisis. Diabetes Research and Clinical Practice. 2020;167:108295.
9. Dahlström U, Follath F, Müller E. Disfungsi hati pada pasien dengan gagal jantung: Patogenesis, diagnosis, dan pengelolaan. European Heart Journal. 2020;41(19):1817-26.
10. Fung A, Murphy P, Blanchard R. Infeksi paru dan efusi pleura: Pertimbangan diagnosis dan pengobatan. Thoracic Disease. 2020;12(4):260-8.
11. Khunti K, Davies M, Kumar S. Pengelolaan diabetes tipe 2 di lingkungan rumah sakit: Peran terapi insulin dan pemantauan glukosa. Diabetic Medicine. 2022;39(1):102-10.
12. Mehta AC, Liao Y. Interaksi kardiopulmoner pada gagal jantung dan pneumonia: Strategi diagnostik dan pengelolaan. Chest. 2022;161(2):402-11.
13. Morice AH, Leech M, Gane J. Patogenesis efusi pleura pada penyakit paru: Tinjauan komprehensif. Journal of Clinical Respiratory Medicine. 2021;47(1):57-64.
14. Van Heerden PV, Beil M, Flaatten H, et al. Pengelolaan multimorbiditas pada pasien lanjut usia: Siap untuk kedokteran presisi di perawatan intensif? Critical Care. 2021;25:330.
- Cover Image
-
- Downloads
- Published
- 2026-03-09
- Section
- Case Report
- License
-
Copyright (c) 2026 Syazili Mustofa, Latansa Amani Raya, Giska Tri Putri, Hendri Busman
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
